Phorbol 12-myristate 13-acetate (PMA), PKC activator
Phorbol 12-myristate 13-acetate (PMA), PKC activator
Be the first to review this product! Submit a review
|
(66 Publications)
Phorbol 12-myristate 13-acetate (PMA) (ab120297) is a potent protein kinase C (PKC) activator in vivo and in vitro. Binds to C1 domain of PKC, induces membrane translocation and enzyme activation. Molecular weight (MW): 616.8; Purity>99%.
- Available in different sizes to fit your experimental needs
- Cited in over 45 publications
查看别名
14-3-3-zetaisoform, AI098070, Atypical protein kinase C-lambda/iota, C80388, CVID9, D14Ertd420e, DXS1179E, EC 2.7.11.13, EPK 2, KPCA_HUMAN, KPCB_HUMAN, KPCD1_HUMAN, KPCD3_HUMAN, KPCD_HUMAN, KPCE_HUMAN, KPCG_HUMAN, KPCI_HUMAN, KPCL_HUMAN, KPCT_HUMAN, KPCZ_HUMAN, Kinase PKC delta, May-01, MGC 5363, MGC125656, MGC125657, MGC126514, MGC141919, MGC26269, MGC26534, MGC49908, MGC57564, NU, OTTHUMP00000001368, OTTHUMP00000043364, OTTHUMP00000043365, OTTHUMP00000044160, OTTHUMP00000067291, PCKd, PKC, PKC 0, PKC 2, PKC MU, PKC ZETA, PKC d, PKC delta, PKC epsilon, PKC h, PKC lambda, PKC lambda/iota, PKC-A, PKC-B, PKC-L, PKC-alpha, PKC-beta, PKC-gamma, PKCC, PKCE, PKCG, PKCI, PKCM, PKCiota, PKCnu, PKD, PKD 3, PKM-zeta, included, PRK D3, PRKC D, PRKC delta, PRKC iota, PRKC-lambda/iota, PRKCA, PRKCB, PRKCB II, PRKCB1, PRKCB2, PRKCE, PRKCG, PRKCI, PRKCL, PRKCM, PRKCN, PRKCT, PRKCZ, PRKD 1, Pkcea, Pkcz, Prkch, Prkcq, Protein Kinase C alpha, Protein Kinase C delta, Protein kinase C, Protein kinase C alpha type, Protein kinase C beta, Protein kinase C beta type, Protein kinase C delta VIII, Protein kinase C delta type, Protein kinase C epsilon, Protein kinase C epsilon type, Protein kinase C eta, Protein kinase C eta type, Protein kinase C gamma, Protein kinase C gamma polypeptide, Protein kinase C gamma type, Protein kinase C iota, Protein kinase C iota type, Protein kinase C mu, Protein kinase C mu type, Protein kinase C nu, Protein kinase C nu type, Protein kinase C theta, Protein kinase C theta type, Protein kinase C zeta, Protein kinase C zeta form, Protein kinase C zeta type, Protein kinase D, Protein kinase D1, Protein kinase D3, Protein kinase EPK 2, R74924, SCA 14, Serine threonine protein kinase, Serine/threonine-protein kinase D1, Serine/threonine-protein kinase D3, Tyrosine protein kinase PRKCD, aPKC-lambda/iota, aPKCzeta, nPKC-D1, nPKC-delta, nPKC-epsilon, nPKC-eta, nPKC-iota, nPKC-mu, nPKC-nu, nPKC-theta, nPKC-zeta, r14-3-3, zetaPKC
- Chemical Structure
Lab
Chemical Structure - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
2D chemical structure image of ab120297, Phorbol 12-myristate 13-acetate (PMA), PKC activator
- FuncS
Unknown
Functional Studies - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Serum starved HeLa cells were incubated at 37°C for 60 minutes with vehicle control (0 μM) and different concentrations of phorbol 12-myristate 13-acetate (PMA) (ab120297) in DMSO. Increased expression of PKC mu (phospho S916) (ab81218) correlates with an increase in phorbol 12-myristate 13-acetate (PMA) concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with ab81218 at 1 μg/ml and ab8227 at 1 μg /ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized THP-1 (human monocytic leukemia cell line) cells, untreated or treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours, then treated with 100ng/ml lipopolysaccharide (LPS) for 7 hours, with 1 μg/ml Brefeldin A (BFA) added after 4 hours, labeling MCP1 with ab214819 at 1/50 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining in THP-1 treated cells.
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- Flow Cyt
Lab
Flow Cytometry - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Flow cytometric analysis of 4% paraformaldehyde-fixed, 0.1% Tween-20-permeabilized THP-1 (human monocytic leukemia cell line) cell line, treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h (Right) / Untreated control (Left) labeling MCP1 with ab214891 at 1/500 dilution. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.
- sELISA
Unknown
Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Sandwich ELISA - IFN gamma Human ELISA Kit (ab46025)
Jurkat were stimulated for 48 hours with 50 ng x mL-1 of PMA (ab120297) and 1 μM Ionomycin (ab120116) and PBMCs were stimulated for 48 hours with 2 % PHA-M (LifeTechnologies). Cell free supernatants were tested, showing results after background signal was subtracted (duplicates +/- SD).
- WB
Supplier Data
Western blot - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 23129404 and PMID : 6423641).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-Interferon gamma antibody [RM1245] (<a href='/products/primary-antibodies/interferon-gamma-antibody-rm1245-ab322926'>ab322926</a>) at 1/1000 dilution
Lane 1:
Untreated No-GFP-CD16.NK-92 (CD16 ectopically expressed natural killer(NK-92®) cell with no GFP tag) whole cell lysate at 20 µg
Lane 2:
No-GFP-CD16.NK-92 treated with 80nM PMA(TPA) (ab120297) and 3uM Ionomycin (<a href='/products/biochemicals/ionomycin-ca2-salt-ca2-ionophore-ab120116'>ab120116</a>) for 5 hours, 300 ng/ml BFA was added for last 4 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 17 kDa,19 kDa,23 kDa,36 kDa
false
Exposure time: 92s
- IP
Lab
Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
CD69 was immunoprecipitated from 0.35 mg Daudi (human Burkitt's lymphoma lymphoblast) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate with ab233396 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab233396 at 1/5,000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5,000 dilution.
Lane 1 : Daudi (human Burkitt's lymphoma lymphoblast) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate 10 μg (Input).
Lane 2 : ab233396 IP in Daudi treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233396 in Daudi treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate (-).
Blocking/Dilution buffer : 5% NFDM/TBST.
false
Exposure time: 30s
- sELISA
Unknown
Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Sandwich ELISA - IL-1ra (Interleukin-1ra) Mouse ELISA Kit (ab113348)
IL-1Ra detected in supernatants from RAW 246.7 control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), or 24 hours with PMA and 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).
- sELISA
Unknown
Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Sandwich ELISA - IL-6 (Interleukin-6) Mouse ELISA Kit (ab100712).
IL-6 detected in supernatants from RAW 246.7 control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), or 24 hours with PMA and 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).
- sELISA
Unknown
Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
Sandwich ELISA - TNF alpha Human ELISA Kit (ab100654)
TNFa detected in supernatants from control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), and PMA with the addition of 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).
- IP
Lab
Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
MCP1 was immunoprecipitated from 0.35 mg of THP-1 (human monocytic leukemia cell line) treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate with ab214819 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab214819 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate 10 μg (Input).
Lane 2 : ab214819 IP in THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab214819 in THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate.
Blocking and dilution buffer : 5% NFDM/TBST.
false
Exposure time: 30s
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PKC family influences many cellular processes including cell proliferation differentiation and survival. These proteins interact with signaling complexes to regulate cellular responses. PKC isoforms participate in assembling or modulating these complexes in response to external stimuli like hormones or stress. Phorbols like PMA activate PKCs altering intracellular signaling pathways. PKCs' role in tumor promotion through these processes makes them significant in cancer research.
Pathways
PKC proteins are essential components in the MAPK/ERK pathway influencing gene expression and cell cycle. They also integrate signals in the PI3K/AKT pathway impacting cell growth and apoptosis. Through these pathways PKC interacts with proteins like RAF MEK in MAPK/ERK and PDK1 mTOR in PI3K/AKT coordinating multiple cellular responses to environmental changes.
文献 (66)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 29:e70525 PubMed40159652
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:3012 PubMed40148355
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:239 PubMed40121481
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of functional biomaterials 15: PubMed39728155
2024
Applications
Unspecified application
Species
Unspecified reactive species
Exploration (Beijing, China) 4:20240027 PubMed39713206
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39457012
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:110622 PubMed39252956
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109823 PubMed38756418
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 17:101 PubMed38745186
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular immunology 21:604-619 PubMed38689020
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com